Form 4: Accustem Sciences Director and 10% Owner Increases Stake Through Pre-Arranged Plan

Gabriele M. Cerrone, a Director and 10% owner of Accustem Sciences Inc., purchased additional common stock through a pre-arranged trading plan.

Summary

• Gabriele M. Cerrone, a Director and 10% owner of Accustem Sciences Inc. (ACUT), acquired additional shares of common stock.
• On June 13, 2025, Mr. Cerrone purchased 2,000 shares of common stock at a price of $1.00 per share.
• On the same date, he purchased an additional 400 shares of common stock at a price of $1.10 per share.
• These transactions were conducted indirectly via Panetta Partners Limited.
• Following these purchases, Mr. Cerrone's indirect beneficial ownership in Accustem Sciences Inc. stands at 6,502,400 shares of common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase of equity securities.

Sentiment

Score: 7

Explanation: The purchase of additional shares by a director and significant owner indicates confidence in the company's prospects, which is generally a positive signal for investors.

Positives

• A Director and 10% owner, Gabriele M. Cerrone, increased his beneficial ownership in Accustem Sciences Inc., signaling confidence in the company's future prospects.
• The purchases were made through a Rule 10b5-1(c) plan, indicating a pre-planned investment strategy rather than a reactive one.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details an insider transaction, which is specific to Accustem Sciences Inc. and its management. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Gabriele M. Cerrone's beneficial ownership of Accustem Sciences Inc. common stock is held indirectly via Panetta Partners Limited.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive signal of confidence from a key director and significant owner, potentially influencing investor sentiment.

Key Dates

Recommendation

Keywords

Accustem Sciences, ACUT, Form 4, insider trading, beneficial ownership, stock purchase, Gabriele M. Cerrone, Panetta Partners Limited, SEC filing, Rule 10b5-1